Muscle-based gene therapy and tissue engineering for the musculoskeletal system

Drug Discovery Today

Volumn 6, Issue 14, 2001, Pages 728-733

  Wright, Vonda J ^a,b   Peng, Hairong ^a,b   Huard, Johnny ^a,b  

^a Growth and Development Laboratory   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GROWTH FACTOR; RECOMBINANT PROTEIN; VIRUS VECTOR;

BIOENGINEERING; BONE GRAFT; CHONDROPATHY; CULTURE MEDIUM; DRUG HALF LIFE; FRACTURE HEALING; GENE CONSTRUCT; GENE THERAPY; HUMAN; IMPLANT; KNEE MENISCUS RUPTURE; LIGAMENT DISEASE; MUSCLE CELL; REVIEW; STEM CELL; TECHNIQUE; TISSUE CULTURE; TISSUE REPAIR;

EID: 0035395103     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01810-4     Document Type: Review

References (54)

1. Gene therapy for arthritis
2. Osteoprogenitor cells within skeletal muscle
3. Ex vivo gene therapy to produce bone using different cell types
4. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
5. Development of approaches to improve cell survival in myoblast transfer therapy
6. Implications of maturation for viral gene delivery to skeletal muscle
7. Muscle maturation: implications for gene therapy
8. Ex vivo gene transfer using adenovirus-mediated full length dystrophin delivery to dystrophic muscles
9. Myoblast-mediated ex vivo gene transfer to mature muscle
10. Myoblast transfer: a possible therapy for inherited myopathies
11. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic muscle-derived stem cells
12. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation
13. Results of a blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy
14. Gene therapy via primary muscle-derived stem cells, long-term expression of factor IX protein following transplantation in vivo
15. Systemic delivery of human growth hormone by injection of genetically engineered muscle-derived stem cells
16. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy
17. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures
18. Long-term correction of rat model of Parkinson's disease by gene therapy
19. Prevention of islet allograft rejection with engineered muscle-derived stem cells expressing FasL in mice
20. Myoblast mediated gene transfer to the joint
21. The use of growth factors, gene therapy and tissue engineering to improve meniscal healing
22. Direct, fibroblast- and myoblast-mediated gene transfer to the anterior cruciate ligament
23. Identification of self-renewing muscle-derived stem cells in the progeny of single human muscle satellite cells
24. Seeking muscle stem cells
25. Evidence in the mouse for self-renewing stem cells in the formation of a segmental longitudinal structure, the myotome
26. Enhancement of fracture healing
27. Simultaneous free-tissue transfer and Ilizarov distraction osteosynthesis in lower extremity salvage: case report and review of literature
28. Segmental bone deficiency after acute trauma. The role of bone transport
29. Autologous bone grafting: complication at the donor site
30. Bone morphogenetic proteins, bone marrow stromal cells and mesenchymal stem cells
31. Current approaches to experimental bone grafting
32. Microvascular anastomoses for bone grafts in the treatment of massive defects in bone
33. Use of muscle cells to mediate gene transfer to the bone defect
34. Primary mouse myoblast purification, characterization and transplantation for cell-mediated gene therapy
35. The efficiency of muscle-derived cell-mediated bone formation
36. The effect of BMP-2 expression on the early fate of skeletal muscle derived cells
37. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone
38. Growth factors improve muscle healing in vivo
39. Use of growth factors to improve muscle healing after strain injury
40. Development of approaches to improve the healing following muscle contusion
41. A method of resurfacing osteoarthritic knee joints. In Proceedings of the British Orthopaedic Association
42. The Pridie debridement operation for osteoarthritis of the knee
43. The resurfacing of adult rabbit articular cartilage by multiple perforations through the subchondral bone
44. Arthorscopic abrasion arthorplasty historical and pathological perspective: present status
45. The role of abrasion arthoplasty and debridement in the management of osteoarthritis of the knee
46. The microfracture technique in the management of complete cartilage defects in the knee joint
47. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage
48. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation
49. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice
50. Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel
51. Transfer of LacZ marker gene to the meniscus
52. Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament